Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Piper Sandler Maintains Overweight on Citigroup, Lowers Price Target to $62

Piper Sandler Maintains Overweight on Citigroup, Lowers Price Target to $62

Piper Sandler analyst Jeffery Harte maintains Citigroup (NYSE:C) with a Overweight and lowers the price target from $70 to $62.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Piper Sandler analyst Jeffery Harte maintains Citigroup (NYSE:C) with a Overweight and lowers the price target from $70 to $62.

News

5 Value Stocks In The Consumer Defensive Sector

By Benzinga Insights

October 6, 10:40 AM

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the…

ADM

Analyst Ratings

Expert Ratings for Snowflake

By Benzinga Insights

Yesterday, 9:03 AM

Within the last quarter, Snowflake (NYSE:SNOW) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

SNOW

Why Is Mereo BioPharma Stock Trading Higher Today?

By Vandana Singh

October 16, 2:31 PM

Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO) released interim data from the Phase 2 portion of the Phase 2/3 Orbit

MREO

US Broadens Investigation Into Ford Engine Failures

By Shivani Kumaresan

October 2, 12:56 PM

The National Highway Traffic Safety Administration (NHTSA) has broadened its probe into approximately 709,000 sport utility vehicles and trucks made by Ford Motor Company (NYSE: F), centered around severe engine breakdowns linked to a malfunctioning valve.

Piper Sandler Maintains Overweight on Citigroup, Lowers Price Target to $62

Related Posts

5 Value Stocks In The Consumer Defensive Sector

Expert Ratings for Snowflake

Why Is Mereo BioPharma Stock Trading Higher Today?

US Broadens Investigation Into Ford Engine Failures